XML 121 R98.htm IDEA: XBRL DOCUMENT v3.25.4
STOCK-BASED INCENTIVE PLANS - Unvested Cash And Stock-settled Rsus, Tsris & Crocei (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 398,000    
Granted (in shares) 255,000    
Vested (in shares) (170,000)    
Forfeitures (in shares) (45,000)    
Unvested, end of period (in shares) 438,000 398,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 58.00    
Granted, weighted-average grant-date fair value (in dollars per share) 46.44 $ 58.87 $ 60.43
Vested, weighted-average grant-date fair value (in dollars per share) 56.47    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 55.30    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 52.15 $ 58.00  
Stock-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 7,119,000    
Granted (in shares) 4,891,000    
Vested (in shares) (3,551,000)    
Forfeitures (in shares) (327,000)    
Unvested, end of period (in shares) 8,132,000 7,119,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 57.63    
Granted, weighted-average grant-date fair value (in dollars per share) 48.85 $ 61.34 $ 59.85
Vested, weighted-average grant-date fair value (in dollars per share) 54.56    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 53.44    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 53.86 $ 57.63  
TSRIs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 1,251,000    
Granted (in shares) 391,000    
Vested (in shares) (388,000)    
Forfeitures (in shares) (3,000)    
Unvested, end of period (in shares) 1,251,000 1,251,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 55.08    
Granted, weighted-average grant-date fair value (in dollars per share) 48.84    
Vested, weighted-average grant-date fair value (in dollars per share) 42.98    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 48.84    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 56.90 $ 55.08  
Payout at vesting percentage 176.00%    
Issued (in shares) 683,358    
CROCEI awards      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 447,000    
Granted (in shares) 391,000    
Vested (in shares) (156,000)    
Forfeitures (in shares) (3,000)    
Unvested, end of period (in shares) 679,000 447,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 54.55    
Granted, weighted-average grant-date fair value (in dollars per share) 48.84    
Vested, weighted-average grant-date fair value (in dollars per share) 42.98    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 48.84    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 53.94 $ 54.55  
Payout at vesting percentage 200.00%    
Issued (in shares) 312,000